The study was conducted to assess the rate of Methicillin-resistant Staphylococcus aureus (MRSA) among patients and healthcare personnel at Manmohan Memorial College and Teaching Hospital, Kathmandu, Nepal and to evaluate the minimum inhibitory concentration of Vancomycin to MRSA isolates.
INTRODUCTION
Staphyolococcus aureus is one of the common human pathogens capable of causing a wide range of infections. A great deal of virulence from the organism occurs through cross infection by patient to patient in hospitals and other institutional settings.
In contrast, healthy individuals have a small risk of invasive infection caused by S. aureus, but they can TUJM VOL. 4, NO. 1, 2017 be carriers of the organism (Foster 2004) . Infection due to Methicillin-Resistant S. aureus (MRSA) are an increasing problem worldwide in community as well as hospital environment (Boyce et al. 2005; Skoy et al. 2006) . The incidence of community-acquired and hospital-acquired S. aureus infections has been rising with increasing emergence of drug-resistant strains called Methicillin resistant S. aureus (MRSA) (Steinberg et al. 1996) . 
RESULTS
Out of total 1433 clinical specimens, S. aureus was isolatesd from 67 specimens (4.7%), among them 57 (85.1%) were found to be MRSA. Whereas from 33 nasal swab specimens, 24 (72.7%) S. aureus were isolated and all of them were found to be MRSA (100%). All of the S. aureus isolates from clinical as well as nasal swab specimens were multi-drug resistant (MDR) (Figure 1 ). 31-40 202 86 3(4.5) 2(2.9) 116 4(5.9) 4(5.9) 6(9) 41-50 124 65 6(9) 6(9) 59 4(5.9) 4(5.9) 10(14.9) 51-60 128 40 1(1.5) 1(1.5) 88 6(9) 5(7.5) 6(9) 61-70 108 55 3(4.5) 3(4.5) 53 5(7.5) 3(4.5) 6(9) 71-80 87 37 2(2.9) 2(2.9) 50 3(4.5) 2(2.9) 4(5.9) >80 89 51 2(2.9) 2(2.9) 38 2(2.9) 2(2.9) 4(5.9) (Table 3) . of MRSA from clinical specimens showed inducible and constitutive Clindamycin resistance respectively.
Whereas, 11 (45.8%) and 4 (16.7%) of MRSA from nasal swabs were found to be inducible and constitutive Clindamycin resistance respectively (Table 4 ). Among nasal swab specimens, 66.7% (16) and 33.3% (8) of S. aureus isolates were found to be strong and nonbiofi lm producer respectively (Table 5 ). On performing MIC of MRSA from clinical specimens, 42.1% (24) of isolates were reported as VSSA (showed MIC value of 2μg/ml), 54.4% (31) as VISA (showed MIC value of 4-8μg/ml) and 3.5% (2) of MRSA isolates were reported as VRSA (showed MIC value of ≥16μg/ml) ( Figure 2 ). Whereas all MRSA isolates from nasal swabs were found to be Vancomycin sensitive (VSSA). 
DISCUSSION
S. aureus has remained a versatile and potent pathogen in humans, since it is one of the most common causes of nosocomial and community acquired infections (Rajbhandari et al. 2003) . S. aureus is a major cause of infectious morbidity and mortality around the world, causing a wide variety of clinical manifestations ranging from localized infection to toxin mediated diseases and invasive blood stream infections (Vandecasteele et al. 2008 The nasal carriage rate of MRSA reported in present study was found to be higher (72.7%) than the previous studies conducted in Nepal by Shakya et al. and Rijal et al. (Rijal et al. 2008; Shakya et al. 2010) .
Penicillin was found resistant to all of MRSA isolates Lama et al. 2017; TUJM 4( 
